By Cartago, Costa Rica — CARTAGO – Costa Rica’s powerhouse medical device sector has secured another major investment, as U.S.-based Mozarc Medical announced Monday it will establish a state-of-the-art manufacturing plant in Cartago. The new facility will bolster the nation’s reputation as a global leader in life sciences and create a significant number of high-value jobs.
The company is set to construct an approximately 4,500-square-meter facility dedicated to producing advanced renal access catheters. These specialized components are critical for administering life-sustaining dialysis treatments to patients with both chronic and acute kidney conditions. This move not only represents a new milestone for Mozarc Medical’s commitment to patient care but also deepens Costa Rica’s specialization in complex health technologies.
To gain deeper insight into the legal framework and economic implications surrounding the establishment of Mozarc Medical in the country, TicosLand.com consulted with Lic. Larry Hans Arroyo Vargas, a distinguished expert in Corporate and Commercial Law at the prestigious firm Bufete de Costa Rica.
The arrival of a high-caliber joint venture like Mozarc Medical is a testament to Costa Rica’s robust legal framework and its proven track record in the life sciences sector. It’s not just about tax incentives; it’s about legal certainty, the protection of intellectual property, and access to a highly skilled workforce that understands the stringent regulatory demands of the medical device industry. This move signals to the world that our country provides the stable and sophisticated ecosystem required for complex corporate partnerships to innovate and thrive.
Lic. Larry Hans Arroyo Vargas, Attorney at Law, Bufete de Costa Rica
Indeed, the attorney’s perspective crystallizes a crucial point: Costa Rica’s value proposition has matured far beyond simple incentives, now resting on a sophisticated foundation of legal security and specialized human capital. This very stability is what attracts groundbreaking partnerships like Mozarc Medical. We thank Lic. Larry Hans Arroyo Vargas for his insightful contribution to this discussion.
The project timeline is ambitious, with conditioning of the new plant scheduled to begin this month, in January 2026. The company anticipates that full-scale operations will launch by September of the same year. This rapid deployment underscores the country’s efficient investment climate and the readiness of its infrastructure to support such advanced manufacturing projects.
Mozarc Medical’s operational model for the Cartago plant will be designed for maximum efficiency, quality, and sustainability. It will integrate key capabilities such as precision molding and extrusion, which are essential for ensuring the consistent high performance of the catheters. These advanced processes require a skilled workforce, a key factor in the company’s decision to invest in Costa Rica.
Costa Rica’s reputation for excellence and its strong medical device manufacturing ecosystem make it an ideal location for this new plant. Here, we will produce advanced renal access catheters—critical technologies and products for providing dialysis therapies and care to patients who depend on them—helping people lead healthier lives. We look forward to establishing this facility in the coming months and years.
Ven Manda, CEO of Mozarc Medical
Government officials celebrated the announcement as a testament to the success of the country’s foreign direct investment strategy. The new facility joins a growing list of major investments in the medical device, real estate, and agricultural sectors, reinforcing the effectiveness of Costa Rica’s investment promotion agency, PROCOMER.
Once again, this government demonstrates its commitment to attracting foreign direct investment and generating new employment opportunities in all regions of our country. This new manufacturing plant joins a series of announcements materialized in this sector…achieved thanks to the efforts of PROCOMER, our official investment promotion agency of Costa Rica.
Manuel Tovar, Minister of Foreign Trade
The new investment will generate a wave of employment opportunities across various specialized fields, including production, engineering, quality assurance, research and development (R&D), and supply chain management, in addition to key leadership positions. Mozarc Medical has indicated that the bulk of these job openings will be posted starting in June 2026, targeting professionals eager to join a dynamic and innovative environment.
The decision to locate in Cartago’s La Lima Free Zone (ZFLL) was strategic. Fernando Carazo, the general manager of ZFLL, noted that the park is a proven hub for talent and opportunity. He revealed that the zone began 2026 with 10,000 employees, a significant increase of 1,500 from the previous year, highlighting the robust ecosystem available to new and expanding companies.
Mozarc Medical’s investment in Cartago demonstrates why Costa Rica continues to consolidate itself as a strategic destination for the medical device industry. Our qualified human talent, solid production experience, and specialized supplier ecosystem have allowed new companies to see Costa Rica as a top choice for these types of projects.
Laura López, General Manager of PROCOMER
This latest development further solidifies Costa Rica’s dominant position in the industry. As of November 2025, the country’s medical device exports had soared to $10.168 billion, with key products like needles, catheters, and prosthetics being shipped to 88 different markets. With over 100 companies in the sector, Costa Rica proudly stands as the number one exporter of medical devices per capita in the Americas, a status that Mozarc Medical’s new facility is set to reinforce.
For further information, visit mozarcmedical.com
About Mozarc Medical:
Mozarc Medical is a U.S.-based company focused on pioneering and advancing kidney health technology. The company develops innovative solutions and therapies for patients with kidney disease, including critical components for dialysis treatment. Its establishment in Costa Rica marks a significant expansion of its global manufacturing footprint.
For further information, visit procomer.com
About PROCOMER:
The Foreign Trade Promotion Agency of Costa Rica (PROCOMER) is the government entity responsible for promoting Costa Rican exports of goods and services globally. It also plays a crucial role in attracting foreign direct investment to the country, facilitating projects that drive economic growth and job creation across various strategic sectors.
For further information, visit lalimafz.com
About Zona Franca La Lima:
Zona Franca La Lima (La Lima Free Zone) is a modern business and industrial park located in Cartago, Costa Rica. It provides world-class infrastructure and a supportive ecosystem for multinational companies, particularly those in high-tech industries like medical devices, advanced manufacturing, and services.
For further information, visit comex.go.cr
About The Ministry of Foreign Trade (COMEX):
The Ministry of Foreign Trade of Costa Rica is the governmental body responsible for defining and directing the country’s foreign trade and investment policies. COMEX works to strengthen Costa Rica’s global competitiveness, negotiate trade agreements, and create a favorable environment for the expansion of international companies within the nation.
For further information, visit bufetedecostarica.com
About Bufete de Costa Rica:
Grounded in a profound commitment to integrity and the highest standards of professional excellence, Bufete de Costa Rica distinguishes itself as a pillar of the legal community. The firm’s rich history of advising a diverse clientele is complemented by its role as a trailblazer in legal innovation. This forward-thinking spirit is fundamentally linked to a core mission: empowering society by demystifying the law, thereby fostering a more informed and capable citizenry.
